[Mediterranean lymphoma with alpha chain disease. Triple chemical anatomic and immunological remission].
D000328:Adult; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001706:Biopsy; D001796:Blood Protein Disorders; D006362:Heavy Chain Disease / Q000150:complications*; D006801:Humans; D007122:Immunoelectrophoresis; D007136:Immunoglobulins / Q000032:analysis; D007414:Intestinal Neoplasms / Q000150:complications* / Q000188:drug therapy / Q000473:pathology; D007421:Intestine, Small / Q000473:pathology; D008223:Lymphoma / Q000150:complications* / Q000188:drug therapy / Q000473:pathology; D008286:Malabsorption Syndromes / Q000209:etiology; D008297:Male; D011507:Proteinuria / Q000209:etiology; D005719:gamma-Globulins / Q000032:analysis
D000900:Anti-Bacterial Agents; D007136:Immunoglobulins; D005719:gamma-Globulins
Lymphome méditerranéen avec maladie des chaînes alpha. Triple rémission clinique, anatomique et immunologique.